Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.55
PDCO's Cash to Debt is ranked lower than
60% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.71 vs. PDCO: 0.55 )
Ranked among companies with meaningful Cash to Debt only.
PDCO' s 10-Year Cash to Debt Range
Min: 0.29  Med: 0.76 Max: No Debt
Current: 0.55
Equity to Asset 0.51
PDCO's Equity to Asset is ranked higher than
65% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.43 vs. PDCO: 0.51 )
Ranked among companies with meaningful Equity to Asset only.
PDCO' s 10-Year Equity to Asset Range
Min: 0.48  Med: 0.62 Max: 0.77
Current: 0.51
0.48
0.77
Interest Coverage 11.08
PDCO's Interest Coverage is ranked lower than
63% of the 27 Companies
in the Global Medical Distribution industry.

( Industry Median: 79.78 vs. PDCO: 11.08 )
Ranked among companies with meaningful Interest Coverage only.
PDCO' s 10-Year Interest Coverage Range
Min: 9.68  Med: 24.67 Max: 2711.33
Current: 11.08
9.68
2711.33
F-Score: 8
Z-Score: 5.19
M-Score: -2.45
WACC vs ROIC
6.76%
13.08%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 8.54
PDCO's Operating margin (%) is ranked higher than
73% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.95 vs. PDCO: 8.54 )
Ranked among companies with meaningful Operating margin (%) only.
PDCO' s 10-Year Operating margin (%) Range
Min: 7.38  Med: 10.27 Max: 12.48
Current: 8.54
7.38
12.48
Net-margin (%) 5.10
PDCO's Net-margin (%) is ranked higher than
66% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.84 vs. PDCO: 5.10 )
Ranked among companies with meaningful Net-margin (%) only.
PDCO' s 10-Year Net-margin (%) Range
Min: 4.71  Med: 6.51 Max: 7.59
Current: 5.1
4.71
7.59
ROE (%) 15.14
PDCO's ROE (%) is ranked higher than
62% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.65 vs. PDCO: 15.14 )
Ranked among companies with meaningful ROE (%) only.
PDCO' s 10-Year ROE (%) Range
Min: 14  Med: 18.86 Max: 22.42
Current: 15.14
14
22.42
ROA (%) 7.73
PDCO's ROA (%) is ranked higher than
78% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.31 vs. PDCO: 7.73 )
Ranked among companies with meaningful ROA (%) only.
PDCO' s 10-Year ROA (%) Range
Min: 7.23  Med: 11.20 Max: 15.63
Current: 7.73
7.23
15.63
ROC (Joel Greenblatt) (%) 47.02
PDCO's ROC (Joel Greenblatt) (%) is ranked higher than
80% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 21.16 vs. PDCO: 47.02 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
PDCO' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 47.25  Med: 65.99 Max: 92.73
Current: 47.02
47.25
92.73
Revenue Growth (3Y)(%) 11.20
PDCO's Revenue Growth (3Y)(%) is ranked higher than
58% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.80 vs. PDCO: 11.20 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
PDCO' s 10-Year Revenue Growth (3Y)(%) Range
Min: 6.9  Med: 12.10 Max: 18.9
Current: 11.2
6.9
18.9
EBITDA Growth (3Y)(%) 5.70
PDCO's EBITDA Growth (3Y)(%) is ranked lower than
53% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.40 vs. PDCO: 5.70 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
PDCO' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 3.4  Med: 11.20 Max: 25.8
Current: 5.7
3.4
25.8
EPS Growth (3Y)(%) 5.30
PDCO's EPS Growth (3Y)(%) is ranked lower than
62% of the 29 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.50 vs. PDCO: 5.30 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
PDCO' s 10-Year EPS Growth (3Y)(%) Range
Min: 1.4  Med: 11.80 Max: 24.5
Current: 5.3
1.4
24.5
» PDCO's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

PDCO Guru Trades in Q2 2014

Third Avenue Management 603,465 sh (New)
First Pacific Advisors 157,000 sh (+15.44%)
Tom Gayner 155,000 sh (+6.90%)
Mario Gabelli 1,800,019 sh (+2.52%)
Donald Yacktman 3,042,000 sh (+0.83%)
Yacktman Focused Fund 650,000 sh (unchged)
Yacktman Fund 2,050,000 sh (unchged)
John Keeley Sold Out
Bill Frels 2,045,634 sh (-0.17%)
Paul Tudor Jones 14,271 sh (-11.99%)
Jeremy Grantham 99,000 sh (-36.98%)
Columbia Wanger 462,120 sh (-63.61%)
» More
Q3 2014

PDCO Guru Trades in Q3 2014

Robert Olstein 119,000 sh (New)
Third Avenue Management 663,021 sh (+9.87%)
Mario Gabelli 1,842,869 sh (+2.38%)
Donald Yacktman 3,047,000 sh (+0.16%)
Tom Gayner 155,000 sh (unchged)
Yacktman Focused Fund 650,000 sh (unchged)
Yacktman Fund 2,050,000 sh (unchged)
First Pacific Advisors 157,000 sh (unchged)
Columbia Wanger Sold Out
Bill Frels 1,688,274 sh (-17.47%)
Jeremy Grantham 72,133 sh (-27.14%)
Paul Tudor Jones 7,900 sh (-44.64%)
» More
Q4 2014

PDCO Guru Trades in Q4 2014

Steven Cohen 47,600 sh (New)
John Hussman 100,000 sh (New)
Paul Tudor Jones 24,200 sh (+206.33%)
Robert Olstein 173,000 sh (+45.38%)
Tom Gayner 155,000 sh (unchged)
Yacktman Fund 2,050,000 sh (unchged)
Yacktman Focused Fund Sold Out
Mario Gabelli 1,799,042 sh (-2.38%)
Bill Frels 1,602,914 sh (-5.06%)
Donald Yacktman 2,385,000 sh (-21.73%)
Jeremy Grantham 54,500 sh (-24.45%)
Third Avenue Management 212,281 sh (-67.98%)
First Pacific Advisors 29,000 sh (-81.53%)
» More
Q1 2015

PDCO Guru Trades in Q1 2015

Robert Olstein 198,000 sh (+14.45%)
Mario Gabelli 1,862,273 sh (+3.51%)
First Pacific Advisors 29,000 sh (unchged)
John Hussman 100,000 sh (unchged)
Louis Moore Bacon 200,000 sh (unchged)
Tom Gayner 155,000 sh (unchged)
Steven Cohen Sold Out
Jeremy Grantham 52,400 sh (-3.85%)
Yacktman Fund 1,950,000 sh (-4.88%)
Donald Yacktman 2,235,000 sh (-6.29%)
Bill Frels 1,448,804 sh (-9.61%)
Third Avenue Management 189,552 sh (-10.71%)
Paul Tudor Jones 7,500 sh (-69.01%)
» More
» Details

Insider Trades

Latest Guru Trades with PDCO

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 21.90
PDCO's P/E(ttm) is ranked higher than
57% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: 24.80 vs. PDCO: 21.90 )
Ranked among companies with meaningful P/E(ttm) only.
PDCO' s 10-Year P/E(ttm) Range
Min: 9.44  Med: 19.67 Max: 40.13
Current: 21.9
9.44
40.13
Forward P/E 18.98
PDCO's Forward P/E is ranked lower than
58% of the 19 Companies
in the Global Medical Distribution industry.

( Industry Median: 17.24 vs. PDCO: 18.98 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 21.90
PDCO's PE(NRI) is ranked higher than
57% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: 24.80 vs. PDCO: 21.90 )
Ranked among companies with meaningful PE(NRI) only.
PDCO' s 10-Year PE(NRI) Range
Min: 9.46  Med: 19.70 Max: 40.16
Current: 21.9
9.46
40.16
P/B 3.34
PDCO's P/B is ranked lower than
60% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.63 vs. PDCO: 3.34 )
Ranked among companies with meaningful P/B only.
PDCO' s 10-Year P/B Range
Min: 1.8  Med: 2.95 Max: 7.23
Current: 3.34
1.8
7.23
P/S 1.12
PDCO's P/S is ranked lower than
52% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.10 vs. PDCO: 1.12 )
Ranked among companies with meaningful P/S only.
PDCO' s 10-Year P/S Range
Min: 0.64  Med: 1.13 Max: 3.04
Current: 1.12
0.64
3.04
PFCF 24.48
PDCO's PFCF is ranked lower than
61% of the 23 Companies
in the Global Medical Distribution industry.

( Industry Median: 20.56 vs. PDCO: 24.48 )
Ranked among companies with meaningful PFCF only.
PDCO' s 10-Year PFCF Range
Min: 9.21  Med: 20.93 Max: 324
Current: 24.48
9.21
324
POCF 18.54
PDCO's POCF is ranked higher than
50% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: 18.54 vs. PDCO: 18.54 )
Ranked among companies with meaningful POCF only.
PDCO' s 10-Year POCF Range
Min: 8.36  Med: 17.42 Max: 39.75
Current: 18.54
8.36
39.75
EV-to-EBIT 14.29
PDCO's EV-to-EBIT is ranked higher than
61% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.29 vs. PDCO: 14.29 )
Ranked among companies with meaningful EV-to-EBIT only.
PDCO' s 10-Year EV-to-EBIT Range
Min: 6.7  Med: 12.40 Max: 24.7
Current: 14.29
6.7
24.7
PEG 4.87
PDCO's PEG is ranked lower than
70% of the 20 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.42 vs. PDCO: 4.87 )
Ranked among companies with meaningful PEG only.
PDCO' s 10-Year PEG Range
Min: 0.96  Med: 1.93 Max: 5.5
Current: 4.87
0.96
5.5
Shiller P/E 23.87
PDCO's Shiller P/E is ranked higher than
72% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 31.94 vs. PDCO: 23.87 )
Ranked among companies with meaningful Shiller P/E only.
PDCO' s 10-Year Shiller P/E Range
Min: 11.03  Med: 20.57 Max: 59.96
Current: 23.87
11.03
59.96
Current Ratio 2.72
PDCO's Current Ratio is ranked higher than
82% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.64 vs. PDCO: 2.72 )
Ranked among companies with meaningful Current Ratio only.
PDCO' s 10-Year Current Ratio Range
Min: 2.07  Med: 2.75 Max: 3.35
Current: 2.72
2.07
3.35
Quick Ratio 1.93
PDCO's Quick Ratio is ranked higher than
82% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.26 vs. PDCO: 1.93 )
Ranked among companies with meaningful Quick Ratio only.
PDCO' s 10-Year Quick Ratio Range
Min: 1.41  Med: 1.99 Max: 2.61
Current: 1.93
1.41
2.61
Days Inventory 56.47
PDCO's Days Inventory is ranked lower than
63% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 49.37 vs. PDCO: 56.47 )
Ranked among companies with meaningful Days Inventory only.
PDCO' s 10-Year Days Inventory Range
Min: 42.98  Med: 49.31 Max: 58.23
Current: 56.47
42.98
58.23
Days Sales Outstanding 53.74
PDCO's Days Sales Outstanding is ranked higher than
51% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 53.74 vs. PDCO: 53.74 )
Ranked among companies with meaningful Days Sales Outstanding only.
PDCO' s 10-Year Days Sales Outstanding Range
Min: 44.31  Med: 49.30 Max: 57.36
Current: 53.74
44.31
57.36

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.68
PDCO's Dividend Yield is ranked higher than
58% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.63 vs. PDCO: 1.68 )
Ranked among companies with meaningful Dividend Yield only.
PDCO' s 10-Year Dividend Yield Range
Min: 0.31  Med: 1.52 Max: 1.88
Current: 1.68
0.31
1.88
Dividend Payout 0.37
PDCO's Dividend Payout is ranked lower than
52% of the 29 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.36 vs. PDCO: 0.37 )
Ranked among companies with meaningful Dividend Payout only.
PDCO' s 10-Year Dividend Payout Range
Min: 0.06  Med: 0.27 Max: 0.37
Current: 0.37
0.06
0.37
Dividend growth (3y) 17.90
PDCO's Dividend growth (3y) is ranked higher than
56% of the 18 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.00 vs. PDCO: 17.90 )
Ranked among companies with meaningful Dividend growth (3y) only.
PDCO' s 10-Year Dividend growth (3y) Range
Min: 0  Med: 0.00 Max: 79.7
Current: 17.9
0
79.7
Yield on cost (5-Year) 9.50
PDCO's Yield on cost (5-Year) is ranked higher than
91% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.21 vs. PDCO: 9.50 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
PDCO' s 10-Year Yield on cost (5-Year) Range
Min: 1.75  Med: 8.59 Max: 10.63
Current: 9.5
1.75
10.63
Share Buyback Rate 3.50
PDCO's Share Buyback Rate is ranked higher than
89% of the 28 Companies
in the Global Medical Distribution industry.

( Industry Median: -0.20 vs. PDCO: 3.50 )
Ranked among companies with meaningful Share Buyback Rate only.
PDCO' s 10-Year Share Buyback Rate Range
Min: 5.3  Med: 0.00 Max: -1.2
Current: 3.5

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 36.26
PDCO's Price/Net Current Asset Value is ranked lower than
96% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.01 vs. PDCO: 36.26 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
PDCO' s 10-Year Price/Net Current Asset Value Range
Min: 6.56  Med: 15.48 Max: 185
Current: 36.26
6.56
185
Price/Tangible Book 10.60
PDCO's Price/Tangible Book is ranked lower than
83% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.50 vs. PDCO: 10.60 )
Ranked among companies with meaningful Price/Tangible Book only.
PDCO' s 10-Year Price/Tangible Book Range
Min: 5.09  Med: 9.40 Max: 48.46
Current: 10.6
5.09
48.46
Price/Projected FCF 1.19
PDCO's Price/Projected FCF is ranked higher than
78% of the 23 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.46 vs. PDCO: 1.19 )
Ranked among companies with meaningful Price/Projected FCF only.
PDCO' s 10-Year Price/Projected FCF Range
Min: 0.76  Med: 1.53 Max: 3.13
Current: 1.19
0.76
3.13
Price/DCF (Earnings Based) 2.07
PDCO's Price/DCF (Earnings Based) is ranked lower than
83% of the 6 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.24 vs. PDCO: 2.07 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 0.99
PDCO's Price/Median PS Value is ranked higher than
68% of the 38 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.22 vs. PDCO: 0.99 )
Ranked among companies with meaningful Price/Median PS Value only.
PDCO' s 10-Year Price/Median PS Value Range
Min: 0.69  Med: 1.15 Max: 2.56
Current: 0.99
0.69
2.56
Price/Graham Number 3.26
PDCO's Price/Graham Number is ranked lower than
71% of the 28 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.79 vs. PDCO: 3.26 )
Ranked among companies with meaningful Price/Graham Number only.
PDCO' s 10-Year Price/Graham Number Range
Min: 1.87  Med: 2.81 Max: 8.55
Current: 3.26
1.87
8.55
Earnings Yield (Greenblatt) (%) 7.00
PDCO's Earnings Yield (Greenblatt) (%) is ranked higher than
69% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.20 vs. PDCO: 7.00 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
PDCO' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 4.1  Med: 8.00 Max: 14.9
Current: 7
4.1
14.9
Forward Rate of Return (Yacktman) (%) 8.92
PDCO's Forward Rate of Return (Yacktman) (%) is ranked lower than
62% of the 26 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.38 vs. PDCO: 8.92 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
PDCO' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: 8.6  Med: 12.45 Max: 27.5
Current: 8.92
8.6
27.5

Analyst Estimate

Apr16 Apr17 Apr18
Revenue(Mil) 5,156 5,720 5,988
EPS($) 2.58 2.96 3.19
EPS without NRI($) 2.58 2.96 3.19

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:ABC, MCK, CAH, SHTDF, HSIC » details
Traded in other countries:PD2.Germany,
Patterson Companies Inc is a distributor of dental supply in North America, companion animal and equine veterinary supply in USA and rehabilitation and assistive products supply. Its dental business has operations in the United States and Canada. Patterson Dental is a full-service supplier to dentists, dental laboratories, institutions, and other healthcare professionals, provides consumable products (including x-ray film, restorative materials, hand instruments and sterilization products); basic and advanced technology dental equipment; practice management and clinical software; patient education systems; and office forms and stationery. Patterson Dental also offers customers related services including dental equipment installation, maintenance and repair, dental office design and equipment financing. It markets its dental products and services through more than 1,500 direct sales representatives, of which approximately 300 are equipment specialists. Its veterinary supply business is a distributor of veterinary supplies to companion-pet (dogs, cats and other common household pets) and equine veterinary clinics across the United States. Patterson Veterinary provides products and services used for the diagnosis, treatment and/or prevention of diseases in companion animals and equine. Its Rehabilitation Supply supply business is a distributor of rehabilitation medical supplies and equipment. Patterson Medical offers distributed and self-manufactured rehabilitation products to health care professionals. The Company's products and services are sold under numerous trademarks including PATTERSON, EAGLESOFT, CAESY, SAMMONS PRESTON, KINETEC, TUMBLE FORMS, INTRAVET, and DIA. The Company is subject to regulation by the Federal Food and Drug Administration, the Drug Enforcement Administration and the U.S. Department of Transportation.
» More Articles for PDCO

Headlines

Articles On GuruFocus.com
Estimate for Patterson Companies' Intrinsic Value Equals the Market Price Mar 24 2015 
Mario Gabelli on Aging America, Alcohol, Twitter, Facebook Dec 17 2013 
Mario Gabelli’s Best Value Plays Nov 21 2012 
Owens & Minor Inc. (OMI) Dividend Stock Analysis Aug 03 2012 
comment on PDCO Jun 30 2012 
The Best Dividends on April 9, 2012 Apr 06 2012 
Owens & Minor Inc. (OMI) Dividend Stock Analysis Sep 16 2011 
WEEKLY CFO SELLS HIGHLIGHT: KRA, CNK, VFC, BCR, PDCO Jun 25 2011 
Guru Stocks Raising Dividends: ADP, INDB, WASH, PDCO, ASH Mar 19 2011 
Patterson Companies Inc. (PDCO) President and CEO Scott P Anderson sells 2,242 Shares Dec 20 2010 

More From Other Websites
Patterson Cos. (PDCO) Stock Closes Up on Medical Business Sale Jul 01 2015
PATTERSON COMPANIES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Jul 01 2015
Sale of Patterson Medical business expected to close in fiscal second quarter. Jul 01 2015
CORRECTED: Patterson Cos.to sell medical business to Madison Dearborn for $715 mln in cash Jul 01 2015
Patterson Companies Announces Definitive Agreement to Sell Its Medical Business to Madison Dearborn... Jul 01 2015
PATTERSON COMPANIES, INC. Financials Jun 30 2015
PATTERSON COMPANIES, INC. Files SEC form 10-K, Annual Report Jun 24 2015
Patterson Companies completes the acquisition of Animal Health International. Jun 22 2015
Sirona Hits 52-Week High on Positive View, Strong Pipeline - Analyst Blog Jun 19 2015
Patterson Boosts Vet Supply, Buys Animal Health International - Analyst Blog Jun 18 2015
PATTERSON COMPANIES, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets,... Jun 17 2015
Patterson Companies completes the acquisition of Animal Health International... Jun 17 2015
CORRECTING and REPLACING Patterson Companies Completes Acquisition of Animal Health International Jun 17 2015
Quality Systems Banks on Strategic Deals, Pipeline Strength - Analyst Blog Jun 16 2015
Patterson Companies Declares Quarterly Dividend Jun 09 2015
Quality Systems CEO to Quit, CareFusion Veteran to Succeed - Analyst Blog Jun 05 2015
Avon Products, Inc. (AVP), Patterson Companies, Inc. (PDCO): Donald Yacktman’s Small-cap Value... Jun 03 2015
Quality Systems Tops Q4 Earnings & Revenues, Shares Up - Analyst Blog May 22 2015
Here’s what CEOs said about the economy this week May 22 2015
Patterson Companies (PDCO) Earnings Report: Q1 2015 Conference Call Transcript May 21 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK